Company intelligence / Profile preview

Nexus Pharmaceuticals

Lincolnshire, Illinois, USAnexuspharma.net ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Nexus Pharmaceuticals has a robust commercial portfolio of FDA-approved injectable drugs addressing critical unmet medical needs. Recent launches include Tranexamic Acid and approvals for Tacrolimus Injection and Methylene Blue Injection. The company focuses on first-to-market generics and specialty injectables with a history of shortages in the U.S., supplying over 5,000 hospitals nationwide. Clinical results are consistent with established efficacy/safety profiles of these generic products.

Therapeutic areas: ImmunologyHematologyOtherCardiovascularNeurology
Modalities: Small molecules (injectable drugs including generics and specialty medications)
Industry: Biotech

Drug pipeline

1 asset

fluorescein

Commercial

Indications: Diagnostic imaging

Partnerships

No major disclosed pharma/biotech partnerships beyond recent facility sale to Eli Lilly & Company for manufacturing assets.

Beyond the preview

Go deeper on Nexus Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nexus Pharmaceuticals.

Explore the full profile